Russell Pachynski MD

Genitourinary Oncology, Hematologic Oncology

Associate Professor of Medicine Division of Oncology

4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 800-647-2098
Fax+1 314-362-3192

Dr. Pachynski is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pachynski's full profile Already have an account?

Summary

Dr. Russell Pachynski is an Associate Professor of Medicine at Washington University in St. Louis School of Medicine, specializing in Oncology with subspecialties in Genitourinary Malignancies. He serves as the Director of Genitourinary Oncology Research for the Division of Oncology. He completed his residency in Internal Medicine and a fellowship in Medical Oncology at Stanford Health Care-Sponsored Stanford University. Dr. Pachynski has notable experience in immunotherapy and various facets of cancer treatment, including prostate, gynecologic, and urologic oncology. He has contributed to numerous publications on prostate cancer and has been involved in clinical trials, focusing on innovative therapies for metastatic hormone-sensitive prostate cancer. His work has been recognized with a Research Scholar Grant from the American Cancer Society.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2006 - 2011
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2003 - 2005
University of Wisconsin School of Medicine & Public HealthClass of 2003
Stanford UniversityB.S., Biology, 1990 - 1994

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MO State Medical License 2014 - 2027
CA State Medical License 2004 - 2024
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Research Scholar Grant American Cancer Society, 2023
CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2012-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017

Clinical Trials

Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer Start of enrollment: 2018 Sep 14
COMPLETED
PHASE1

Publications & Presentations

PubMed

Evaluating Interim Progression: First PosttherapyLu-PSMA SPECT/CT Relative to Baseline PSMA PET/CT.
Ashwin Singh Parihar, Farrokh Dehdashti, Niharika Pant, Shubha G Ravindra, Russell Pachynski
Journal of Nuclear Medicine. 2026-07-23
Automating neoantigen selection for personalized cancer vaccine design.
Jennie X Yao, Kartik Singhal, Susanna Kiwala, Evelyn Schmidt, S Peter Goedegebuure
Medrxiv. 2026-07-01
AR and Beyond: ctDNA Maps Resistance Evolution in mCRPC.
Pradeep S Chauhan, Russell K Pachynski, Christopher A Maher, Aadel A Chaudhuri
Clinical Cancer Research. 2026-06-15

Press Mentions

Physician-Scientists Receive Scholar-Innovator AwardJuly 24th, 2024
Physician-Scientists Receive Scholar-Innovator AwardJune 10th, 2024
Physician-Scientists Receive Scholar-Innovator AwardJune 7th, 2024

Grant Support

Human Prostate Tumor Atlas CenterWASHINGTON UNIVERSITY2024–2029
Human Prostate Tumor Atlas CenterWASHINGTON UNIVERSITY2024–2029
Novel ctDNA biomarker for androgen therapy in metastatic prostate cancerWASHINGTON UNIVERSITY2023–2028